Dasatinib – SRC/ABL Kinase Inhibitor | 50mg × 30 Tablets
Dasatinib – Senolytic SRC/ABL Kinase Inhibitor | 50mg × 30 Tablets | RUO Grade | BlueBiotech®
Senolytic Research Compound Targeting Senescent Cells via Kinase Pathways | Made in USA | Research Use Only
| Field Name | Example Value |
|---|---|
| Product Name | Dasatinib – Senolytic SRC/ABL Kinase Inhibitor |
| Product Code | BB-RUO-DASATINIB-50 |
| Product Type | Small Molecule – Research Compound |
| Category | Anti-Aging / Senolytics / Signal Transduction / Oral Compounds |
| Manufacturer | BlueBiotech® Research Facility |
| Appearance | White to off-white oral tablets |
| Dosage / Units | 50mg per tablet × 30 tablets per bottle |
| Purity | ≥99% (HPLC) |
| Quantity Options | 30 tablets / 60 tablets (custom available) |
| Storage | Store at room temperature; keep dry and protected from light |
| Shelf Life | 24 months unopened |
| Packaging | White HDPE bottle with tamper-evident RUO labeling |
| Manufacturer Origin | USA – Made in USA |
| Use Classification | RUO – Research Use Only (Not for human or veterinary use) |
| Tags | Dasatinib, senolytic, anti-aging RUO, BlueBiotech, cellular senescence, longevity research, Dasatinib + Quercetin, BCR-ABL inhibitor, kinase inhibitor |
Dasatinib is a senolytic research compound known for selectively clearing senescent cells in aging models. Widely used in combination with Quercetin, it supports preclinical studies in lifespan extension, metabolic restoration, and regenerative medicine. Supplied as 50mg RUO-grade oral tablets (30 count) with ≥99% purity.
For Research Use Only – Not intended for human or veterinary use.
⚠️This product is labeled for Research Use Only (RUO). Not for human or veterinary therapeutic use.
See RUO Declaration for more info.
Dasatinib – Senolytic SRC/ABL Kinase Inhibitor | 50mg × 30 Tablets | RUO Grade | BlueBiotech®
Product Overview
Dasatinib is a dual-function small-molecule kinase inhibitor best known for its senolytic activity—the ability to selectively induce apoptosis in senescent cells, which accumulate with age and contribute to chronic inflammation and tissue dysfunction. In recent years, Dasatinib has emerged as a cornerstone compound in anti-aging research, with growing evidence supporting its role in improving healthspan and restoring regenerative capacity.
In combination with Quercetin, Dasatinib has shown robust senolytic effects in multiple tissues, including adipose, bone marrow, endothelium, and skeletal muscle. While originally developed as a BCR-ABL/SRC inhibitor in oncology, its application in senescence-targeted research is now widespread and well-documented.
This RUO-grade compound is provided in 50mg oral tablets (30 count), manufactured in the USA by BlueBiotech® with ≥99% purity verified by HPLC.
🔬 Learn more from scientific literature:
Key Features
✅ Potent senolytic agent for age-related research models
✅ Promotes selective apoptosis in senescent cells
✅ 50mg oral tablet formulation – 30 tablets per bottle
✅ ≥99% HPLC purity; consistent lab-grade quality
✅ Dual kinase inhibitor: BCR-ABL / SRC pathways (secondary application)
✅ Made in USA by BlueBiotech®
✅ RUO-compliant: Not for human or veterinary use
Specifications
Compound Name: Dasatinib
CAS Number: 302962-49-8
Molecular Formula: C₂₂H₂₆ClN₇O₂S
Molecular Weight: 488.01 g/mol
Purity: ≥99% (HPLC)
Form: Off-white oral tablets
Content: 50mg per tablet × 30 tablets per bottle
Storage: Store at room temperature; keep dry and protected from light
Shelf Life: 24 months unopened
Use Classification: Research Use Only (RUO)
Research Applications
-
Senescent cell clearance in aging and metabolic disease models
-
Healthspan and lifespan extension studies
-
Dasatinib + Quercetin combinatorial senolytic therapy
-
Stem cell rejuvenation and tissue regeneration
-
Signal transduction research involving SRC and BCR-ABL
⚠️ Compliance Statement
This product is strictly intended for research use only (RUO). It is not for use in humans or animals, and it is not approved for clinical, therapeutic, or diagnostic applications.
Researchers are responsible for ensuring appropriate regulatory compliance in their respective jurisdictions.
Tags / Keywords
Dasatinib RUO, senolytic research, cellular senescence, anti-aging compound, Dasatinib + Quercetin, BlueBiotech, SRC inhibitor, longevity research, RUO tablets, healthspan extension
Also in GLP-1 Peptides:
Similar Products
![Rybelsus® Oral Semaglutide Tablets [Japan Edition]](https://www.bluebiotech.health/wp-content/uploads/2024/11/RYBELSUS-Semaglutide-Tablets-14.0-600x800.jpg)
![Ozempic® Semaglutide Injection 4.0mg/3.0ml [China Edition]](https://www.bluebiotech.health/wp-content/uploads/2024/11/3-2-600x800.jpg)
Corporate Advantages
High-Purity Standards
Tested for purity and identity. COAs available
for all RUO compounds
Buyer Protection
Protected and discrete fulfillment
available upon request
Research-Grade Support
Dedicated service for labs, clinics, and
compounders handling RUO items.
Lab-Grade Quality Assurance
All compounds are tested for-identity and purity, COAs and supporting documentation are available upon request.
Strict RUO Compliance
All products are labeled for Researd Use Only (RUO), Not intended for human or veterinary therapeutic or diagnostic purposes.
Lab-Grade Quality Assurance
Custom branding.
white-label optionons and formulation assistancee available for eligible research institutions and partners.
Custom R&D & APl Synthesis
We support original
pharmaceutica solutions.custom research projects, and NDC-grade materials-meeting speifica.tions for qualified partners.
Serving Professionals Across the U.S.& Mexico
Trusted by MedSpas, wellness clinics and licensed compounders under licensed compounding relationships.
Secure & Discreet Fulfillment
Cold-chain shipping : private, plain.wrap packaging, and tracking for sensitive RUO materials.
⚠️ All compounds are provided strictly for Research Use Only (RUO). BLUEBIOTECH does not endorse or support clinical, therapeutic, or diagnostic use of its products unless under licensed compounder supervision.